摘要
目的 探讨布地奈德、阿奇霉素联合特布他林治疗小儿急性支气管炎的临床效果。方法 选取2013年1月-2016年1月江山市人民医院诊治的急性支气管炎患儿50例,随机分为观察组和对照组,每组各25例。对照组用阿奇霉素治疗,观察组用布地奈德＋阿奇霉素＋特布他林治疗;将2组患者各项实验数据详细记录并作对比分析,探讨了布地奈德、阿奇霉素联合特布他林治疗小儿急性支气管炎的临床效果。结果 治疗后,观察组（布地奈德＋阿奇霉素＋特布他林）临床治疗效果优于对照组（阿奇霉素）临床治疗效果,患儿临床症状改善情况优于对照组,组间比较差异有统计学意义（P〈0.05）。结论 急性支气管炎患儿选择布地奈德＋阿奇霉素＋特布他林联合治疗效果显著,可于短时间内有效改善患儿临床症状,值得临床上广泛用于治疗急性支气管炎患儿。
Objective To discuss the clinical effect of the treatment of acute bronchitis in children with the treatment of children with the treatment of children with acute bronchitis. Methods 50 patients with pediatric acute bronchitis from January 2013 to January 2016 were selected,and randomly divided into observation group and control group,25 cases in each groups.The control group with azithromycin treatment, the observation group with cloth to Ned ＋ archie LeiSu ＋ terbutaline therapy; To two groups of patients with detailed record and analysis of the experimental data, discussed the budesonide, azithromycin combined terbutaline clinical effect for the treatment of infantile acute bronchitis. Results After treatment,the observation group （budesonide ＋ archie LeiSu ＋ terbutaline） clinical curative effect is better than that of control group （azithromycin） clinical curative effect, clinical symptoms improved situation is better than that of control group, compare the difference between groups was statistically significant （P〈0.05）. Conclusion Children with acute bronchitis choose budesonide ＋ archie LeiSu ＋ terbutaline combined treatment effect significantly, can effectively improve clinical symptoms in a short time, is widely used in clinical treatment of children with acute bronchitis.
出处
《中国生化药物杂志》
CAS
2017年第8期137-138,141,共3页
Chinese Journal of Biochemical Pharmaceutics
